ALACHUA, Fla.--(BUSINESS WIRE)--
Florida Biologix®, a full-service biopharmaceutical
development and contract manufacturing organization, provided cGMP
manufacturing services to National Taiwan University Hospital under a
contract signed in March 2008. Florida Biologix produced, purified, and
tested a clinical batch of their novel gene therapy for a Phase I
clinical trial of a rare genetic disease ? AADC deficiency. The trial
was led by Dr. Paul Wuh-Liang Hwu. Results of the clinical trial were
published in the May 16th issue of Science Translational
Medicine.
"We are excited to have supported this clinical project with such
promising results," said Dr. Richard Snyder, Director of Florida
Biologix and co-author on the publication. "Our specialized experience
in the manufacture, testing and filling of biopharmaceuticals combined
with our unique business model made us an ideal partner to work with the
National Taiwan University Hospital. As with all of our clients, we
worked closely with their team to achieve their manufacturing
objectives."
About Florida Biologix
Florida Biologix® (www.floridabiologix.ufl.com)
is a Phase I/II biologics contract development, manufacturing and
testing organization, based at the University of Florida's Center of
Excellence for Regenerative Health Biotechnology, that offers a range of biopharmaceutical
services to the biotechnology industry and research institutes. They
provide exceptional customer service, close project collaboration, and
clear and honest communication. Florida Biologix' in-house quality
departments reside within the 23,000 square foot, state-of-the-art GMP
facility, designed for multi-product bulk substance manufacturing,
cell therapy product manufacturing and aseptic vial filling; an adjacent
building houses the 5,000 square foot process development laboratories.
Florida Biologix staff are not only experts in biologics manufacturing,
based on a foundation of science and engineering, but are also
approachable, trustworthy, and believe that the best way to build
long-term relationships with clients is through open communication and
on-time delivery.
